U.S. Patent and Trademark Office building in Alexandria, VA. Photo: Diego M. Radzinschi/ALM
Although the U.S. Supreme Court just spoke a few weeks ago, the Arthrex Appointments Clause litigation isn’t over yet.
At least two patent owners represented by prominent law firms told the U.S. Court of Appeals for the Federal Circuit on Wednesday that the remedy devised by the Supreme Court and implemented by the U.S. Patent and Trademark Office is constitutionally infirm.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
